BofA analyst Alec Stranahan raised the firm’s price target on MeiraGTx (MGTX) to $14 from $12 and keeps a Buy rating on the shares, citing a ...

Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Meiragtx Holdings (MGTX – Research Report) today and set a price ...

MeiraGTx (NASDAQ:MGTX – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, ...

Shares of MeiraGTx Holdings (NASDAQ:MGTX) traded higher in the premarket on Thursday after the company, with its Q4 2024 results, announced an agreement with AI-focused research firm Hologen Limited ...

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in ...

In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that ...

It reported third-quarter adjusted sales of $689.445 million, according to Benzinga Pro. Avi Kapoor MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study MeiraGTx Holdings' (NASDAQ ...

In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a renowned ...